Targeted Oncology

Experts in lung oncology review 3 clinical cases and discuss individualized treatment approaches for each patient.

Michael Wang, MD, reacts to recent data and the potential to treat patients with relapsed or refractory mantle cell lymphoma with KTE-X19, an investigational CAR T-cell therapy.